Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients

American Journal of Transplantation

Volumn 7, Issue 5, 2007, Pages 1131-1139

  Binggeli, S ^a   Egli, A ^a   Schaub, S ^b   Binet, I ^c   Mayr, M ^b   Steiger, J ^b   Hirsch, H H ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Division of Nephrology   (Switzerland)

Author keywords

BK virus interstitial nephritis; Kidney transplantation; Nephropathy; Polyoma; Polyomavirus; T cells

Indexed keywords

GAMMA INTERFERON; LEFLUNOMIDE; PROTEIN VP1; VIRUS T ANTIGEN;

ADULT; AGED; ARTICLE; BK VIRUS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; JC VIRUS; KIDNEY TRANSPLANTATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; VIRUS LOAD;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ANTIGENS, VIRAL, TUMOR; BK VIRUS; CAPSID PROTEINS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSION; INTERFERON TYPE II; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; POLYOMAVIRUS INFECTIONS; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIRUS REPLICATION;

EID: 34247329101     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01754.x     Document Type: Article

References (33)

1. Hirsch HH. Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant 2002 2 : 25 30.
2. Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005 79 : 1277 1286.
3. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003 3 : 611 623.
4. Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of polyomavirus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002 13 : 2145 2151.
5. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyomavirus-associated interstitial nephritis in the allograft kidney. Transplantation 1999 67 : 103 109.
6. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005 68 : 1834 1839.
7. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971 1 : 1253 1257.
8. Crowder CD, Gyure KA, Drachenberg CB et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transplant 2005 5 : 1151 1158.
9. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971 1 : 1257 1260.
10. Knowles WA, Pipkin P, Andrews N et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003 71 : 115 123.
11. Hirsch HH. BK virus: Opportunity makes a pathogen. Clin Infect Dis 2005 41 : 354 360.
12. Randhawa P, Uhrmacher J, Pasculle W et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005 77 : 238 243.
13. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002 347 : 488 496.
14. Nickeleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000 342 : 1309 1315.
15. Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirus-associated nephropathy: Update on BK virus-specific immunity. Transpl Infect Dis 2006 8 : 86 94.
16. Bohl DL, Storch GA, Ryschkewitsch C et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005 5 : 2213 2221.
17. Comoli P, Azzi A, Maccario R et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 2004 78 : 1229 1232.
18. Comoli P, Basso S, Azzi A et al. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol 2003 14 : 3197 3204.
19. Ginevri F, De Santis R, Comoli P et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003 75 : 1266 1270.
20. Brennan DC, Agha I, Bohl DL et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005 5 : 582 594.
21. Drachenberg CB, Papadimitriou JC, Wali R et al. Improved outcome of polyomavirus allograft nephropathy with early biopsy. Transplant Proc 2004 36 : 758 759.
22. Funk GA, Steiger J, Hirsch HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006 193 : 80 87.
23. Trofe J, Hirsch HH, Ramos E. Polyomavirus-associated nephropathy: Update of clinical management in kidney transplant patients. Transpl Infect Dis 2006 8 : 76 85.
24. Chen Y, Trofe J, Gordon J et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006 80 : 3495 3505.
25. Hammer MH, Brestrich G, Andree H et al. HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity. Am J Transplant 2006 6 : 625 631.
26. Binggeli S, Egli A, Dickenmann M, Binet I, Steiger J, Hirsch HH. BKV replication and cellular immune responses in renal transplant recipients. Am J Transplant 2006 6 : 2218 2219.
27. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001 184 : 1494 1495 author reply 1495-1496.
28. Sester U, Gartner BC, Wilkens H et al. Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am J Transplant 2005 5 : 1483 1489.
29. Randhawa PS, Popescu I, Macedo C et al. Detection of CD8 + T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients. Hum Immunol 2006 67 : 298 302.
30. Binggeli S, Egli A, Steiger J, Hirsch HH. BKV-specific cellular immune response to VP1 and large T-antigen after polyomavirus-associated nephropathy (Abstract 83). World Transplant Congress 2006, vol 6. Boston, MA : Am J Transplant 2006; 6: 94.
31. Bunde T, Kirchner A, Hoffmeister B et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 2005 201 : 1031 1036.
32. Krymskaya L, Sharma MC, Martinez J et al. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005 79 : 11170 11178.
33. Drachenberg CB, Papadimitriou JC, Hirsch HH et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 2004 4 : 2082 2092.